Literature DB >> 10985260

Induction of cyclooxygenase-2 expression during HIV-1-infected monocyte-derived macrophage and human brain microvascular endothelial cell interactions.

C F Pereira1, L A Boven, J Middel, J Verhoef, H S Nottet.   

Abstract

Human immunodeficiency virus type-1 (HIV-1)-associated dementia (HAD) is a neurodegenerative disease characterized by HIV infection and replication in brain tissue. HIV-1-infected monocytes overexpress inflammatory molecules that facilitate their entry into the brain. Prostanoids are lipid mediators of inflammation that result from cyclooxygenase-2 (COX-2) activity. Because COX-2 is normally induced during inflammatory processes, the aim of this study was to investigate whether COX-2 expression is up-regulated during monocyte-brain endothelium interactions. In vitro cocultures of HIV-infected macrophages and brain endothelium showed an up-regulation of COX-2 expression by both cell types. This up-regulation occurs via an interleukin-1beta (IL1beta)-dependent mechanism in macrophages and via an IL-1beta-independent mechanism in endothelial cells. Thus, interactions between HIV-infected monocytes and brain endothelium result in COX-2 expression and, as such, might contribute to the neuropathogenesis of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10985260

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  13 in total

1.  COX1 and COX2 expression in non-neuronal cellular compartments of the rhesus macaque brain during lentiviral infection.

Authors:  Candan Depboylu; Eberhard Weihe; Lee E Eiden
Journal:  Neurobiol Dis       Date:  2011-01-08       Impact factor: 5.996

2.  The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E2 levels.

Authors:  Daniel W Fitzgerald; Karl Bezak; Oksana Ocheretina; Cynthia Riviere; Thomas C Wright; Ginger L Milne; Xi Kathy Zhou; Baoheng Du; Kotha Subbaramaiah; Erin Byrt; Matthew L Goodwin; Arash Rafii; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-01

Review 3.  Contextual functions of antigen-presenting cells in the gastrointestinal tract.

Authors:  John R Grainger; Michael H Askenase; Fanny Guimont-Desrochers; Denise Morais da Fonseca; Yasmine Belkaid
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

4.  Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells.

Authors:  Maarten Buitendijk; Susan K Eszterhas; Alexandra L Howell
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-05       Impact factor: 2.205

5.  Cyclooxygenase-1 and -2 are required for production of infectious pseudorabies virus.

Authors:  Neelanjana Ray; Margaret E Bisher; L W Enquist
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 6.  Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system.

Authors:  Jonathan Bertin; Corinne Barat; Sylvie Méthot; Michel J Tremblay
Journal:  Retrovirology       Date:  2012-01-11       Impact factor: 4.602

7.  Cyclooxygenase-2 is involved in HIV-1 Tat-induced inflammatory responses in the brain.

Authors:  Govinder Flora; Hong Pu; Bernhard Hennig; Michal Toborek
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 4.103

8.  Low-dose aspirin (acetylsalicylate) prevents increases in brain PGE2, 15-epi-lipoxin A4 and 8-isoprostane concentrations in 9 month-old HIV-1 transgenic rats, a model for HIV-1 associated neurocognitive disorders.

Authors:  Helene C Blanchard; Ameer Y Taha; Stanley I Rapoport; Zhi-Xin Yuan
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2015-01-13       Impact factor: 4.006

9.  HIV-1 Structural Proteins Serve as PAMPs for TLR2 Heterodimers Significantly Increasing Infection and Innate Immune Activation.

Authors:  Bethany M Henrick; Xiao-Dan Yao; Kenneth Lee Rosenthal
Journal:  Front Immunol       Date:  2015-08-19       Impact factor: 7.561

10.  Prostaglandin E2 reduces the release and infectivity of new cell-free virions and cell-to-cell HIV-1 transfer.

Authors:  María Isabel Clemente; Susana Álvarez; María Jesús Serramía; Marta Martínez-Bonet; María Ángeles Muñoz-Fernández
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.